ZAMORA, Leonid D.

ZAMORA, Leonid D.

Dr. Leonid D. Zamora is an Assistant Professor I at the Department of Medicine, UST Faculty of Medicine & Surgery. He graduated from the UST Faculty of Medicine and Surgery, earning a Doctor of Medicine degree in 2006. Dr. Zamora completed his residency in Internal Medicine at Makati Medical Center from 2009 to 2011. Following this, he pursued a fellowship program focused on Rheumatology, Clinical Immunology, and Osteoporosis at the UST Hospital (USTH) from 2013 to 2015. The Research Center for Health Sciences has appointed Dr. Zamora as the Research Coordinator for the Department of Medicine. He is also an Alternate Member of the Research and Ethics Board of the UST Faculty of Medicine and Surgery. Additionally, he is the Assistant Research Head for the Department of Medicine. Moreover, he holds the position of the Coordinator for Research at the Department of Medical Education & Research (DMER). He serves as the Adviser for Research at the Department of Internal Medicine of USTH. Furthermore, he is the Assistant Training Officer in USTH Rheumatology Fellowship Training. Dr. Zamora is a Fellow of the Philippine College of Physicians and the Philippine Rheumatology Association. He is also a member of the Asia-Pacific Lupus Collaboration, the Asia Pacific League for Associations of Rheumatology (APLAR) Young Rheumatologists, and the APLAR SLE Special Interest Group. Dr. Zamora holds the position of the head of research of the Philippine Rheumatology Association SLE-Special Interest Group.

Updates

UST recognizes research achievements of faculty

UST recognizes research achievements of faculty

A total of 121 faculty members were recognized in the…

Academic Qualifications

Research Highlights

Research Interests

Academic Qualifications

Degrees

  • Doctor of Medicine, University of Santo Tomas – Manila, Philippines, 2002-2006
  • Bachelor of Science in Biology, University of Santo Tomas – Manila, Philippines, 1998-2002

Eligibility

  • Professional Regulation Commission Physician Licensure Examination

Postgraduate Trainings  

  • Fellowship in Rheumatology, Clinical Immunology and Osteoporosis, University of Santo Tomas Hospital – Manila, Philippines, 2013-2015
  • Residency in Internal Medicine, Makati Medical Center, 2009-2012 
  • Postgraduate Medical Internship, Department of Health – Philippine Centers for Specialized Healthcare, 2006-2007

Research Highlights

  • His research interests focus on Rheumatology and Clinical Immunology, particularly Systemic Lupus Erythematosus and other Rheumatologic Autoimmune Diseases. These affiliations reflect his dedication to the field of Rheumatology and Clinical Immunology. His work and contributions in these roles highlight his commitment to advancing medical research and patient care. Dr. Zamora was honored with the Cardinal Ceferino Gonzales Award for Indexed Publications for 2021-2022 in recognition of his significant contributions to medical research.

Research Interests

  • Molecular Medicine
  • Rheumatology and Clinical Immunology
  • Systemic Lupus Erythematosus and other Rheumatologic Autoimmune Diseases

Courses Handled

Major Recognitions

Professional Activities

Courses Handled

  • Medicine 1 – Physical Diagnosis (2nd year Medical Students)
  • Medicine 2 (3rd year Medical Students)
  • Medicine 3 – Clerkship (4th year Medical Students) 

Major Recognitions

  • Cardinal Ceferino Gonzales Award for Indexed Publications, 2021-2022
  • Top 20 Scientists included in Alper-Doger Scientific Index World: Asia Scientists and University Rankings, 2022

Professional Activities

Academic Appointment 

  • Assistant Professor 1, Department of Medicine, UST Faculty of Medicine & Surgery 

Administrative Appointments/Positions 

  • Research Coordinator, Department of Medicine, Research Center for Health Sciences, UST Faculty of Medicine and Surgery
  • Alternate Member, Research and Ethics Board, UST Faculty of Medicine and Surgery
  • Assistant Research Head, Department of Medicine, UST Faculty of Medicine and Surgery
  • Coordinator for Research, Department of Medical Education and Research, UST Hospital
  • Adviser for Research, Department of Internal Medicine, UST Hospital
  • Assistant Training Officer, Rheumatology Fellowship Training, UST Hospital
  • Head, Research Committee, Philippine Rheumatology Association SLE-SIG

Past Positions

  • AdHoc Committee Member on Core Curriculum Development, Philippine Rheumatology Association, 2019-2020
  • Steering Committee, Systemic Lupus Erythematosus CPG, 2021-2023 
  • Visiting Consultant, Jose R. Reyes Memorial Medical Center, 2019-2020

Professional Affiliations

  • Fellow, Philippine College of Physicians
  • Fellow, Philippine Rheumatology Association
  • Member, Asia-Pacific Lupus Collaboration
  • Member, Asia Pacific League for Associations of Rheumatology (APLAR) Young Rheumatologists
  • Member, APLAR, SLE Special Interest Group

Hospital Affiliations 

  •  Active Consultant, UST Hospital

Selected Publications

Selected Publications

  • SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus–an analysis of anti-double-stranded DNA monitoring. Rheumatology (Oxford, England), kead231-kead233
  • Association of Modified Systemic Lupus Erythematosus Responder Index Attainment with Long‐Term Clinical Outcomes: A Five‐Year Prospective Study. Arthritis & Rheumatology, Vol 75, issue 3, Pages 401-410
  • Association of Sustained Lupus Low Disease Activity State with Improved Outcomes in SLE: A Multinational Prospective Cohort Study. Arthritis & Rheumatology 2023
  • Target-Oriented Clinical Skill Enhancement (TOCSE) Builds Up Confidence of Fourth-Year Medical Students During First-Time Patient Encounter: An Effective Bridging Tool After Online Didactic Undergraduate Classes During the COVID-19 Pandemic. Journal of Medicine, University of Santo Tomas, Vol 6, S1, Pages 114-125.
  • Double Contour Sign In Early Detection Of Gout Among Asymptomatic Hyperuricemic Filipino Patients: A Single Center Tertiary Hospital Observational Study. Journal of Medicine, University of Santo Tomas, 6(S1), 85-89.
  • Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study. Arthritis Research & Therapy, 24(1), 1-10.
  • Patterns of Medication Use in Systemic Lupus Erythematosus: A Multicenter Cohort Study. Arthritis care & research, 74(12), 2033-2041.
  • Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study. The Lancet Rheumatology, 4(12), e822-e830.
  • Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study. The Lancet Rheumatology, 4(12), e831-e841.
  • Physician Global Assessment International Standardisation Consensus in Systemic Lupus Erythematosus: the PISCOS study. The Lancet Rheumatology, 4(6), e441-e449Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study. Rheumatology, 60(11), 5185-5193.
  • The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus. The Lancet Rheumatology, 3(7), e517-e531.COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration. International journal of rheumatic diseases, 23(9), 1255-1257.
  • MEDICATION USE IN SYSTEMIC LUPUS ERYTHEMATOSUS DATA FROM A MULTICENTRE COHORT STUDY. INTERNAL MEDICINE JOURNAL, 50, 18-19.Lupus education for physicians and patients in a resource-limited setting. Clinical Rheumatology, 39, 697-702.
  • Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus. International Journal of Rheumatic Diseases, 23(2), 197-202.
  • Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study. The Lancet Rheumatology, 2(1), e24-e30. 
  • Longitudinal associations of active renal disease with irreversible organ damage accrual in systemic lupus erythematosus. Lupus, 28(14), 1669-1677.
  • Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study. The Lancet Rheumatology, 1(2), e103-e110.
  • Serotonin syndrome masquerading as disease flare in lupus nephritis with end‐stage renal disease. International Journal of Rheumatic Diseases, 22(10), 1933-1936.
  • Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study. The Lancet Rheumatology, 1(2), e95-e102.
  • Development of the Asia Pacific lupus collaboration cohort. International journal of rheumatic diseases, 22(3), 425-433.Assessment of ACR and SLICC classification criteria in the Asia Pacific Lupus Collaboration Cohort. In internal medicine journal (vol. 48, pp. 38-39).